FullPAC and Sixtyfour Announce Exclusive Distribution Partnership to Provide AI Candidate Research and Due-Diligence Reports

VIRGINIA BEACH, VA, June 16, 2026 (GLOBE NEWSWIRE) — FullPAC, Inc. (“FullPAC”), an AI-powered platform trusted by more than 5,000 U.S. political organizations, and Sixtyfour AI Inc. (“Sixtyfour”) today announced an exclusive distribution partnership under which FullPAC will serve as the sole distributor of Sixtyfour’s AI-generated candidate research reports — Background, OSINT, Digital Footprint, Campaign Finance analyses, and more — to certain U.S. political campaigns and organizations, which are expected to be available on demand through the GOTV platform.

FullPAC and Sixtyfour Announce Exclusive Distribution Partnership to Provide AI Candidate Research and Due-Diligence Reports

VIRGINIA BEACH, VA, June 16, 2026 (GLOBE NEWSWIRE) — FullPAC, Inc. (“FullPAC”), an AI-powered platform trusted by more than 5,000 U.S. political organizations, and Sixtyfour AI Inc. (“Sixtyfour”) today announced an exclusive distribution partnership under which FullPAC will serve as the sole distributor of Sixtyfour’s AI-generated candidate research reports — Background, OSINT, Digital Footprint, Campaign Finance analyses, and more — to certain U.S. political campaigns and organizations, which are expected to be available on demand through the GOTV platform.

Syntec Optics (Nasdaq: OPTX) Lands Space Optics Order, Boosting Total to $4.3M for Weekly Satellite Launches

ROCHESTER, NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a Space and Defense deep tech leader, today announced nearly $2.4 million in new purchase orders for the product line, scaled for higher production in Q1 2026, to support weekly launches of Low Earth Orbit satellites. This order expands the previously announced nearly $1.9 million Q1 order, bringing total recent awards for this product line to nearly $4.3 million, with full delivery expected before the middle of next quarter. 

Syntec Optics (Nasdaq: OPTX) Lands Space Optics Order, Boosting Total to $4.3M for Weekly Satellite Launches

ROCHESTER, NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a Space and Defense deep tech leader, today announced nearly $2.4 million in new purchase orders for the product line, scaled for higher production in Q1 2026, to support weekly launches of Low Earth Orbit satellites. This order expands the previously announced nearly $1.9 million Q1 order, bringing total recent awards for this product line to nearly $4.3 million, with full delivery expected before the middle of next quarter. 

Kite Realty Group Completes $136 Million in Strategic Acquisitions and $255 Million in Strategic Dispositions

INDIANAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) — Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, today announced the completion of significant capital allocation activity, including the acquisition of two high-growth, open-air shopping centers, the disposition of six lower growth, non-core assets, and the execution of additional share buybacks.

Nocera Announces Strategic Investment in CampaignPulse.ai, Expanding Artificial Intelligence Portfolio and Advancing Nocera Holdings Growth Strategy

Strategic Investment Advances Nocera’s Growth and Artificial Intelligence Strategy Through Exposure to Emerging Campaign Intelligence, Predictive Analytics and Decision Intelligence Markets Powered by Next-Generation AI Simulation Technologies

Strategic Investment Advances Nocera's Growth and Artificial Intelligence Strategy Through Exposure to Emerging Campaign Intelligence, Predictive Analytics and Decision Intelligence Markets Powered by Next-Generation AI Simulation Technologies

Kite Realty Group Completes $136 Million in Strategic Acquisitions and $255 Million in Strategic Dispositions

INDIANAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) — Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, today announced the completion of significant capital allocation activity, including the acquisition of two high-growth, open-air shopping centers, the disposition of six lower growth, non-core assets, and the execution of additional share buybacks.

Nocera Announces Strategic Investment in CampaignPulse.ai, Expanding Artificial Intelligence Portfolio and Advancing Nocera Holdings Growth Strategy

Strategic Investment Advances Nocera’s Growth and Artificial Intelligence Strategy Through Exposure to Emerging Campaign Intelligence, Predictive Analytics and Decision Intelligence Markets Powered by Next-Generation AI Simulation Technologies

Strategic Investment Advances Nocera's Growth and Artificial Intelligence Strategy Through Exposure to Emerging Campaign Intelligence, Predictive Analytics and Decision Intelligence Markets Powered by Next-Generation AI Simulation Technologies

Fairfax Announces Completion of Kennedy Wilson Take-Private Transaction

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) announced today that the previously announced acquisition of Kennedy-Wilson Holdings, Inc. (“Kennedy Wilson”) by an entity affiliated with a consortium (the “Consortium”) led by William McMorrow, Chairman and Chief Executive Officer of Kennedy Wilson, certain other senior executives of the Company (collectively, the “KW Management Group”), and certain affiliates of Fairfax for US$10.90 per share in cash pursuant to a Merger Agreement has been completed. The KW Management Group, led by William McMorrow, has effective and operational control of and continues to lead and have ultimate responsibility for Kennedy Wilson and its subsidiaries while Fairfax holds a majority of the economic interest.

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

Vancouver, Canada, June 16, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of dosing for all 24 participants in Cohorts 1 through 4 of Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder (AUD).